Quantcast

Latest Melanoma Stories

2014-09-02 08:30:29

First Marketing Authorization Application for an Oncolytic Immunotherapy in the European Union THOUSAND OAKS, Calif., Sept. 2, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) via the centralized procedure for talimogene laherparepvec seeking approval for the treatment of adults with melanoma that is regionally or distantly metastatic. Talimogene laherparepvec is an...

2014-08-27 12:31:25

LONDON, Aug. 27, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Medical Affairs Reputations in Oncology: Oncologists Rate Key Products and Companieshttps://www.reportbuyer.com/product/2313371/Medical-Affairs-Reputations-in-Oncology-Oncologists-Rate-Key-Products-and-Companies.html As the oncology drug market continues to face significant road bumps in terms of development costs and pricing requirements, the role of Medical Affairs teams working with...

2014-08-22 23:06:46

Recent News Articles Give Five Tips But Bio Logic Aqua Research Founder Sharon Kleyne Offers Three Additional Equally Important Tips Grants Pass, OR (PRWEB) August 22, 2014 A recent widely circulated news article contains a list of “Five tips for summer sun safety.” Sharon Kleyne, international water advocate and host of the Sharon Kleyne Hour Power of Water completely agrees with the five tips but adds three additional tips that she believes are less obvious and seldom mentioned but...

sunscreen video screenshot
2014-08-22 06:41:33

Rayshell Clapper for redOrbit.com - Your Universe Online Most people know that the sun damages skin. This damage can lead to freckles, wrinkles, sun spots, or even cancer. Of all the skin cancers, melanoma is the most deadly. Yet many people do not wear sunscreen on a daily basis. Some refuse to do so for one reason or another while others simply have not incorporated it into their morning routine out of laziness or even simply because they have just forgotten to do so. Some actively...

2014-08-20 23:03:26

http://www.heartbeatexperts.com/ -- This Flash Report is a top-line view into Heartbeat Experts’ perspectives on stakeholder management needs for the melanoma market. New York, US (PRWEB) August 20, 2014 Understanding the impact of clinical, patient advocate, market access, governmental and physician stakeholders networks impacting the launch of new melaoma products in Europe, Asia-Pacific, Latin America, US, Canada, and Emerging Markets. This Flash Report is a top-line view into...

Specialized Immune Cells Could Stop Cancer Spread
2014-08-18 03:54:50

Walter and Eliza Hall Institute of Medical Research Melbourne researchers have revealed the critical importance of highly specialized immune cells, called natural killer cells, in killing melanoma cells that have spread to the lungs. These natural killer cells could be harnessed to hunt down and kill cancers that have spread in the body. The team, from the Walter and Eliza Hall Institute, also found natural killer cells were critical to the body’s rejection of donor bone marrow...

2014-08-12 08:30:30

SAN DIEGO, Aug. 12, 2014 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV), a developer of cell-free molecular diagnostics, announced today that K. Peter Hirth, Ph.D., has joined the Company's Scientific Advisory Board. Dr. Hirth is an industry leader and innovator with over 30 years of biotechnology and pharmaceutical discovery and development experience. A pioneer in the field of personalized medicine, Dr. Hirth led the organizations that developed both Sutent(®) and Zelboraf(®);...

2014-08-12 08:29:26

Array planning for potential return of MEK inhibitor BOULDER, Colo., Aug. 12, 2014 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY) today reported results for the fourth quarter and full year of its fiscal year ending June 30, 2014. http://photos.prnewswire.com/prnvar/20121029/LA02195LOGO Ron Squarer, Chief Executive Officer of Array, noted, "The Array-invented MEK inhibitors, binimetinib and selumetinib, are currently enrolling six Phase 3 trials, and each of our partners has...

2014-08-11 12:22:42

SYRACUSE, N.Y., Aug. 11, 2014 /PRNewswire/ -- WHO: BlueRock Energy, Inc. is hosting the 1st Annual "Save the Skin" Golf & Dinner Fundraiser to support the Melanoma Research Foundation (MRF), the largest independent organization devoted to increasing awareness about the prevention, diagnosis and treatment of melanoma. WHAT: The "Save the Skin" Golf & Dinner Fundraiser encourages the general public to attend and enjoy a day of golf, dinner and...

2014-08-08 11:22:18

OSA A new hand-held device that uses lasers and sound waves may change the way doctors treat and diagnose melanoma, according to a team of researchers from Washington University in St. Louis. The instrument, described in a paper published today in The Optical Society’s (OSA) journal Optics Letters, is the first that can be used directly on a patient and accurately measure how deep a melanoma tumor extends into the skin, providing valuable information for treatment, diagnosis or...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related